Search Results 821-830 of 16276 for Chronic Lymphocytic Leukemia

  1. Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Rhabdomyosarcoma - Symptoms and causes - Mayo Clinic

    Treatment depends on where the cancer starts, how large it grows and whether it spreads to other parts of the body. Research into diagnosis and treatment have ...

  3. Publications - James M. Foran, M.D. - Mayo Clinic

    ... Acute Lymphoblastic Leukemia in First Complete Remission. Transplant Cell ... Real-world experience with ponatinib therapy in chronic phase chronic myeloid ...

  4. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

    Diagnosis of AML-M3 (or acute promyelocytic leukemia). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

  5. Clinical trials - Oncology (Medical)

    ... leukemia (AML). ... A Study to Evaluate Web-Based Physical Activity Intervention in Children and Adolescents with Newly Diagnosed Acute Lymphoblastic Leukemia in ...

  6. Publications - Karl N. Krecke, M.D. - Mayo Clinic

    Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017 Sep 1; 140 (9): ...

  7. Mayo Clinic Q&A podcast: Accurate diagnosis is key to treating lymphoma

    The lymphatic system includes the lymph nodes or glands, the spleen, the thymus gland, and bone marrow. While many types of lymphoma exist, the main subtypes ...

  8. Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia - Mayo Clinic

    ... leukemia. Drugs used in chemotherapy, such as cytarabine, daunorubicin ... chronic myelogenous leukemia (CML) are not eligible; patients with known ...

  9. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    Has a prior history of T-cell lymphoblastic lymphoma (T-LBL)/T-cell acute lymphoblastic leukemia (T-ALL) or B-cell acute lymphoblastic leukemia (B-ALL). 6 ...

  10. Study of Biomarker-Based Treatment of Acute Myeloid Leukemia - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Scottsdale ...